Immunogenicity, Safety, and Tolerability of MF59-Adjuvanted Versus Non-Adjuvanted Influenza Vaccines in Patients With HIV-1 Infection

Clinical trial NCT01032408 · COMPLETED

Trial details

NCT number: NCT01032408
Sponsor: Chiltern Pesquisa Clinica Ltda
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

H1N1 Influenza Virus Human Immunodeficiency Virus Type 1 (HIV-1) Infection

Start date: 2010-04-01
Primary completion: 2011-09-01
Enrollment: 154

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.